Wednesday Dec 4
The Washington Post
Ditching Big Drugmakers for Biotech Brings Leukemia Boon: Health
Fifty-five, pensionless and assuming he'd have to work until he died, Roger Ulrich had a decision to make.
Tue Dec 03, 2013
Novartis Veterinary Unit Said to Draw Interest From Merck, Lilly
Novartis AG 's animal-health business is drawing interest from drugmakers including Eli Lilly & Co.
Mon Dec 02, 2013
Merck & Co., Inc. To Shutter Irish Plant, 570 Jobs To Go
Merck is axing jobs but others are hiring ! Check it out! Merck & Co has announced plans to shutter a plant in Ireland by the end of 2017 which will affect 570 staff.
Forest Labs Plans To Buy Schizophrenia Drug, Cut Costs
Forest Laboratories Inc, which is facing patent expirations on several of its biggest drugs, on Monday said it planned to buy rights to a new schizophrenia drug from Merck & Co and cut its annual operating costs by $500 million in 2016.
Tue Nov 26, 2013
Merck & Co Price Target Raised to $54.00 at BMO Capital Markets
BMO Capital Markets' price objective indicates a potential upside of 8.74% from the company's current price.
FDA Approves Merck & Co., Inc.'s NOXAFIL (posaconazole) Delayed-Release Tablets
FDA Approves Merck's NOXAFILA Delayed-Release Tablets WHITEHOUSE STATION, N.J.-- -- Merck , known as MSD outside the United States and Canada, today announced that the U.S. Food and Drug Administration has approved NOXAFILA 100 mg delayed-release tablets.
Fri Nov 22, 2013
Alcoa Inc. (NYSE:AA) and Merck & Co. Inc. (NYSE:MRK) Added to Growing ...
Growing Stock Report expands its NYSE Gainers Weekly Watch List adding Alcoa Inc. and Merck & Co.
Thu Nov 21, 2013
The Jersey Journal
Drugmakers shuttering sites leaves N.J. towns facing $29 million tax vacuum
Four northern New Jersey towns face the loss of $29 million of combined revenue as some of the world's largest pharmaceutical companies depart, complicating Republican Governor Chris Christie's drive to boost business and cut the highest U.S. property taxes.
Wed Nov 20, 2013
Yehong Zhang Joins Aetna as General Manager, Greater China
Based in Aetna's offices in Shanghai, Dr. Zhang will be responsible for the company's growth in China, Hong Kong, Macau and Taiwan.
Tue Nov 19, 2013
Health News Digest
Merck for Mothers Working to End the Tragedy of Women in America Dying in Childbirth and Pregnancy
WHITEHOUSE STATION, N.J., Nov. 19, 2013 -- Merck , known as MSD outside the United States and Canada, today announced that Merck for Mothers has launched programs aimed at decreasing the number of women across the United States who die from or suffer severe complications related to pregnancy and childbirth.
Mon Nov 18, 2013
Interim Data to Be Presented for MK-3475, Merck & Co., Inc.??'s...
Merck , known as MSD outside the United States and Canada, will present additional data from patients with advanced melanoma from the Phase IB trial of MK-3475 on Monday, Nov. 18 at the 10th International Congress of the Society for Melanoma Research in Philadelphia.
Fri Nov 15, 2013
Merck sells ophthalmic line to generic competitor
Generic drug maker Akorn Inc. said it has bought the U.S. rights to three branded ophthalmic products from Merck and Co.
Merck & Co., Inc.'s New HPV Vaccine Could Rejuvenate The Market...
Despite being hampered both by apathy and resistance in recent years, the human papillomavirus vaccine market is expected to receive an additional boost from Merck's novel candidate V503, which offers protection against five HPV types not covered by current vaccines; however, effective marketing efforts must be made to ensure sufficient uptake of ... (more)
Mon Nov 11, 2013
EMD Millipore Wins R&D Magazine 100 Award for its Direct Detect Protein Quantitation System
The Direct DetectA system was recognized as one of R&D Magazine's 100 most innovative and technologically significant products to be introduced into the marketplace in the year 2012 for being the first mid-infrared biomolecular quantitation system.
Merck & Co., Inc.??'s Investigational Grass Sublingual Allergy...
Merck , known as MSD outside the United States and Canada, today announced data for its investigational Timothy grass sublingual allergy immunotherapy tablet from a study involving 1,501 North American adult and pediatric patients.
Sat Nov 09, 2013
ALK's partner in North America, Merck, reports Phase III data on...
ALK's partner for North America, Merck reported that data from a pivotal Phase III clinical trial with its investigational grass sublingual allergy immunotherapy tablet were presented at the 2013 annual meeting of the American College of Allergy, Asthma & Immunology in Baltimore, USA during 7-11 November.